Deferred Tax Assets, Valuation Allowance of PLUS THERAPEUTICS, INC. from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
PLUS THERAPEUTICS, INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • PLUS THERAPEUTICS, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $25,910,000, a 15% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

PLUS THERAPEUTICS, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $25,910,000 +$3,335,000 +15% 31 Dec 2025 10-K 12 Mar 2026 2025 FY
Q4 2024 $22,575,000 +$3,089,000 +16% 31 Dec 2024 10-K 12 Mar 2026 2025 FY
Q4 2023 $19,486,000 +$3,394,000 +21% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q4 2022 $16,092,000 +$4,558,000 +40% 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q4 2021 $11,534,000 -$93,208,000 -89% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q4 2020 $104,742,000 +$1,920,000 +1.9% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q4 2019 $102,822,000 +$1,731,000 +1.7% 31 Dec 2019 10-K 22 Feb 2021 2020 FY
Q4 2018 $101,091,000 +$4,002,000 +4.1% 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q4 2017 $97,089,000 -$37,784,000 -28% 31 Dec 2017 8-K 10 Sep 2019
Q4 2016 $134,873,000 +$3,686,000 +2.8% 31 Dec 2016 10-K 09 Mar 2018 2017 FY
Q4 2015 $131,187,000 -$1,396,000 -1.1% 31 Dec 2015 10-K 24 Mar 2017 2016 FY
Q4 2014 $132,583,000 +$10,133,000 +8.3% 31 Dec 2014 10-K 11 Mar 2016 2015 FY
Q4 2013 $122,450,000 +$20,974,000 +21% 31 Dec 2013 10-K 16 Mar 2015 2014 FY
Q4 2012 $101,476,000 +$12,276,000 +14% 31 Dec 2012 10-K 14 Mar 2014 2013 FY
Q4 2011 $89,200,000 31 Dec 2011 10-K 15 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.